stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Operating cash flow
Warby Parker Inc.'s operating cash flow for fiscal 2025 was $110.8M, up 12.2% from $98.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $102.1M. Over the past ten years it has ranged from −$32.0M (fiscal 2021) to $110.8M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. Warby Parker Inc. ranks 22nd of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $110.8M | 12.19% |
| FY2024 | $98.7M | 61.90% |
| FY2023 | $61.0M | 488.15% |
| FY2022 | $10.4M | — |
| FY2021 | −$32.0M | — |
| FY2020 | $32.8M | 53.12% |
| FY2019 | $21.4M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $24.7M | (16.53%) |
| Jun 2026 | $29.6M | 20.84% |
| Mar 2026 | $24.5M | 5.41% |
| Dec 2025 | $23.3M | 29.38% |
| 22 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | $289.2M |
| ICUI ICU Medical, Inc. compare | $279.2M |
| XRAY DENTSPLY SIRONA Inc. compare | $272.0M |
| WRBY Warby Parker Inc. | $102.1M |
| LMAT LeMaitre Vascular, Inc. compare | $76.2M |
| ATRC AtriCure, Inc. compare | $68.5M |
| AZTA Azenta, Inc. compare | $38.0M |
| PLSE Pulse Biosciences, Inc compare | −$63.3M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$87.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement